Suggestions
Thomas A. Peyser PhD
Medical device executive with experience in R&D, clinical and regulatory
Thomas A. Peyser PhD, Co-founder and Chief Scientist of Mode AGC
Thomas A. Peyser PhD is a medical device executive with over 20 years of experience in R&D, clinical studies, and regulatory affairs for continuous glucose monitoring systems and artificial pancreas technology.12
Key Accomplishments
- Co-founded Mode AGC (Automated Glucose Control LLC), an early-stage medical device company developing closed-loop insulin delivery systems12
- Served as Vice President of Science & Technology at DexCom, leading collaborations with artificial pancreas research groups worldwide2
- Awarded a multi-million dollar grant from the National Institute of Standards and Technology (NIST) Advanced Technology Program (ATP) for development of a subcutaneous fluorescent glucose sensor while at Lawrence Livermore National Laboratory2
- Received the Department of Energy and The White House Office of Science and Technology "Bright Lights Award" and the Federal Laboratory Consortium Award for excellence in technology transfer for work with MiniMed2
- Holds 10 issued patents and has filed 40 additional patents2
Education
- PhD in Physics from University of Maryland College Park2
- Bachelor of Arts (B.A.) in Physics from New York University, magna cum laude2
Current Roles
- Co-founder and Chief Scientist at Mode AGC (Automated Glucose Control) LLC12
- Medical device consultant at Innovative Device Design for Medicine (IDDM) Consulting2
Thomas Peyser's expertise and leadership have been instrumental in advancing continuous glucose monitoring and artificial pancreas technologies to improve the lives of people with diabetes.
Highlights
Feb 14 · investors.insulet.com
Insulet Acquires Assets of Automated Glucose Control LLC (AGC)
Apr 1 · fiercebiotech.com
Biolinq raises an extra $4.75M in series A for trials of its painless ...
Feb 25 · prnewswire.com
Insulet Announces Development Partner for the OmniPod Artificial ...